Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Effectiveness of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder
NCT05916339Phase 4Recruiting
- Start
- Oct 2023
- Primary completion
- Jan 2027
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 2
01
Overview
A Phase 4 trial of amphetamine, methylphenidate hydrochloride extended-release chewable tablet, guanfacine, Clonidine Lauriad in attention deficit hyperactivity disorder (ADHD). Started Oct 2023; status: recruiting.
02
Drugs
amphetaminemethylphenidate hydrochloride extended-release chewable tabletguanfacineClonidine Lauriad
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT05916339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05916339.